| Website | newscienceventure... |
| Phone | 212 950 2562 |
| Employees | |
| Founded | 2004 |
| Description | NY VC in early/late stage in performance |
New Science Ventures (NSV) is a New York-based venture capital firm which invests in both early and late stage companies using novel scientific approaches to address significant unmet needs and create order of magnitude improvements in performance. NSV manages over $125 million and has invested in more than 20 companies located in the US, Europe, India and China in the life sciences and information technology sectors.
| Company | Date | Round | Size | Participants |
| BioVex | 3/09 | Series F | $40M | 7 |
| Seahorse Bioscience | 3/09 | Series D | $6M | 7 |
| Achronix Semiconductor | 10/08 | Series B | $52M | 5 |
| TherOx | 2/08 | Series E | $30M | 3 |
| FlowCardia | 8/07 | Series C | $30M | 9 |
| Achronix Semiconductor | 2007 | Series A | $25.4M | 4 |